期刊文献+

非酒精性脂肪性肝病合并多囊卵巢综合征的相关性研究

The relationship between non-alcoholic fatty liver disease and metabolic profiles in women with PCOS
下载PDF
导出
摘要 目的调查多囊卵巢综合征(PCOS)患者非酒精性脂肪性肝病(NAFLD)的发病情况,探讨NAFLD与PCOS患者代谢特征的相关性。方法选择PCOS组145例及对照组122例为研究对象,测定血清空腹血糖(FBG)、餐后2h血糖、空腹胰岛素(FINS)、餐后2h胰岛素、总甘油三酯(TG)、总胆固醇(Chol)、低密度脂蛋白(LDL)、高密度脂蛋白(HDL)、谷丙转氨酶(ALT)、谷草转氨酶(AST),以超声诊断脂肪肝。结果 PCOS组NAFLD的发生率明显高于对照组,差异有统计学意义(P<0.01);PCOS组的ALT、餐后2h INS、HOMA-IR高于对照组,差异有统计学意义(P<0.01)。PCOS患者伴与不伴NAFLD组比较,NAFLD组的ALT、餐后2h INS、BMI、FINS、HO-MA-IR、TG明显高于非NAFLD组,差异有统计学意义(P<0.05);NAFLD的发生率与ALT、餐后2 h INS、BMI、FINS、HOMA-IR呈正相关。结论 PCOS患者易患NAFLD,对肥胖及胰岛素抵抗的PCOS患者应常规进行转氨酶及肝脏超声检查。 Objective To explore the relationship between non-alcoholic fatty liver disease and metabolic profiles in women with PCOS by investigating the prevalence of NAFLD in polycystic ovary syndrome(PCOS) women.Methods The data of patients were acquired from 145 women with PCOS by Rotterdam consensus criteria and 122 women selected as controls,serum glucose and lipid profile,insulin,liver enzymes and body mass index(BMI) were measured.Fatty liver was diagnosed by ultrasound.Results Patients with PCOS showed a higher prevalence of NAFLD than that in control group.Serum ALT and serum insulin(2-hours after take oral glucose load) and HOMA-IR were significantly higher(P0.01) in women with PCOS compared to controls.Compared with patients without NAFLD,patients with NAFLD had significantly increased ALT,BMI,FINS,serum insulin(2-hours after take oral glucose load),HOMA-IR and TG(P0.05).The occurrence of NAFLD showed significant positive correlations with ALT,BMI,FINS,serum insulin(2-hours after take oral glucose load) and HOMA-IR.Conclusion PCOS appears to be more prone to develop NAFLD,PCOS women with IR and over weight should be screened for NAFLD.
出处 《宁夏医学杂志》 CAS 2011年第9期817-819,共3页 Ningxia Medical Journal
关键词 非酒精性脂肪性肝病 多囊卵巢综合征 代谢指标 Non-alcoholic fatty liver disease Polycystic ovary syndrome Petabolic profiles
  • 相关文献

参考文献11

  • 1中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊断标准[J].中华肝脏病杂志,2003,11(2):71-71. 被引量:1367
  • 2The Rotterdam ESHRE/ASRM-Sponsored PCOS Work Shop Group.Revised 2003 consensus on diagnosic criteria and long term health risks related to polycystic ovary syndrome[J].Fertil Steril,2004,81(1):19-25.
  • 3Rice S,Christoforidis N,Gadd C,et al.Impaired insulin-dependent glucose metabolism in granulose-lutein cells from anovulatory women with polycystic ovaries[J].Hum Reprod,2005,20(2):373-381.
  • 4Woods YL,Petrie JR,Sutherland C.Dissecting insulin signaling pathways:individualised therapeutic targets for diagnosis and treatment of insulin resistant states[J].Endocr Metab Immune Disord Drug Targets,2009,9(2):187-198.
  • 5Cerda C,Perez-Ayuso RM,Riquelme A,et al.Nonalcoholic fatty liver disease in women with polycystic ovary syndrome[J].Hepatol,2007,47:412-417.
  • 6黄健,黄群,伍丽群,陈小华,何剑琴,徐平如,郑昌京.非酒精性脂肪性肝病与多囊卵巢综合征相关性研究[J].实用肝脏病杂志,2010,13(3):198-200. 被引量:6
  • 7林芸,彭幼玲,闻安民.多囊卵巢综合征113例临床及代谢特点[J].广东医学,2008,29(6):988-990. 被引量:12
  • 8曲中玉,石玉华,赵冬妮,姜晶晶,马增香,陈子江.肥胖对多囊卵巢综合征患者非酒精性脂肪性肝病的影响[J].中华医学杂志,2010,90(29):2036-2039. 被引量:6
  • 9Economou F,Xyrafis X,Livadas S,et al.In overweight/obese but not in normal-weight women,polycystic ovary syndrome is associated with elevated liver enzymes compared to controls[J].Hormones (Athens),2009,8(3):199-206.
  • 10Preiss D,Sattar N,Harborne L,et al.The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome[J].Int J Clin Pract,2008,62:1337-1343.

二级参考文献18

  • 1王良岸,杨冬梓,冯淑英,陈小莉,孙艳梅.285例广东籍多囊卵巢综合征患者的特征[J].广东医学,2006,27(10):1472-1473. 被引量:9
  • 2Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..酒精性肝病诊疗指南[J].实用肝脏病杂志,2007,10(1):4-5. 被引量:73
  • 3CERDA C,PEREZ-AYUSO RM,RIQUELME A,et al.Nonalcoholic fatty liver disease in women with polycystic ovary syndrome[J].J Hepatol,2007,47(3):412-417.
  • 4GAMBARIN-GELWAN M,KINKHABWALA SV,SCHIANO TD,et al.Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome[J].Clin Gastroenterol Hepatol,2007,5(4):496-501.
  • 5THE ROTTERDAM ESHRE/ASRM-SPONSORED PCOS CONSENSUS WORKSHOP GROUP.Revised 2003 consensus on diagnostic criteria and longterm health risks related to polyeystie ovary syndrome (Pcos)[J].Hum Reprod,2004,19:41-47.
  • 6SETJI TL,BROWN AJ.Polycystic ovary syndrome:diagnosis and treatment[J].Am J Med,2007,120(2):128-132.
  • 7EHRMANN DA.Polycystic ovary syndrome[J].N Eagl J Med,2005,352(12):1223-1236.
  • 8SCHWIMMER JB,KHORRAM O,CHIU V,et al.Abnormal aminotransferase activity in women with polycystic ovary syndrome[J].Fertil Steril,2005,83(2):494-497.
  • 9CARMINA E.Need for liver evaluation in polycystic ovary syndrome[J].J Hepatol,2007,47(3):313-315.
  • 10CRESSWELL J,FRASER R,BRUCE C,et al.Relationship between polycystic ovaries,body mass index and insulin resistance[J].Acta Obstet Gynecol Scand,2003,82:61-64.

共引文献1386

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部